What you'll learn

  • Evaluate emerging strategies in the use of psychotropic medications in the treatment of major depression and anxiety disorders and integrate psychopharmacologic treatments into psychotherapy strategies in treating depressed and anxious patents
  • Describe strategies for the psychopharmacological and psychotherapeutic management of treatment resistant depression
  • Summarize the emerging role of ketamine in the treatment of major depression and suicidal behavior
  • Explore the role of novel enhancements to treatment of mood disorders including omega 3 fatty acids, 1 methylfolate and zinc
  • View the course registration page for additional learning objectives

Course description

This is accredited, livestreamed course offered by Beth Israel Deaconess Medical Center is part of the 32nd Annual Summer Seminar series.

Select the Take Course button to view additional information on the course registration page.

Contact ceprograms@hms.harvard.edu with questions.

Associated Schools

  • Harvard Medical School

Enroll now.
Take course